IDERA PHARMACEUTICALS, INC. Business Finance Contracts & Agreements
78 Contracts & Agreements
- Assignment Agreements (1 contract)
- Equity Distribution Agreements (1)
- Funding Agreements (1)
- Note Agreements (2)
- Purchase Agreements (7)
- Registration Rights Agreements (12)
- Security Agreements (2)
- Share Agreements (4)
- Stock Agreements (20)
- Subscription Agreements (1)
- Underwriting Agreements (3)
- Warrant Agreements (24)
- General Assignment for the Benefit of Creditors, dated as of August 16, 2023, by and between Aceragen, Inc. and ACG (ABC), LLC (Filed With SEC on August 16, 2023)
- Security Agreement, dated as of July 11, 2023, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P (Filed With SEC on July 11, 2023)
- Bridge Funding Agreement, dated as of July 11, 2023, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P (Filed With SEC on July 11, 2023)
- Amended and Restated Warrant to Purchase Common Stock, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P., dated March 30, 2023 (Filed With SEC on April 13, 2023)
- Form of Idera Pharmaceuticals, Inc. Convertible Unsecured Promissory Notes (Filed With SEC on February 3, 2023)
- Amendment to Stock and Warrant Purchase Agreement, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P., dated October 25, 2021 (Filed With SEC on November 14, 2022)
- Stock and Warrant Purchase Agreement, by and between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P., dated March 24, 2021 (Filed With SEC on November 14, 2022)
- Amendment to the Idera Pharmaceuticals, Inc. 2017 Employee Stock Purchase Plan (Filed With SEC on June 24, 2022)
- Amendment to the Securities Purchase Agreement and Registration Rights Agreement, dated December 11, 2020, by and among Idera Pharmaceuticals, Inc., Pillar Partners Foundation,... (Filed With SEC on December 15, 2020)
- First Amendment to Purchase Agreement, dated as of September 2, 2020, by and between Idera Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 3, 2020)
- Securities Purchase Agreement, dated July 13, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on July 15, 2020)
- Registration Rights Agreement, dated July 13, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on July 15, 2020)
- Form of Common Warrant (Filed With SEC on July 15, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on July 15, 2020)
- Securities Purchase Agreement, dated April 7, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on April 7, 2020)
- Registration Rights Agreement, dated April 7, 2020, by and among Idera Pharmaceuticals, Inc. and Pillar Partners Foundation, L.P (Filed With SEC on April 7, 2020)
- Form of Common Warrant (Filed With SEC on April 7, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on April 7, 2020)
- Warrant Amendment Agreement, dated as of December 23, 2019, by and among Idera Pharmaceuticals, Inc. and certain holders of warrants named therein (Filed With SEC on March 12, 2020)
- Registration Rights Agreement, dated December 23, 2019, by and among Idera Pharmaceuticals, Inc. and certain investors named therein (Filed With SEC on March 12, 2020)
- Form of Vincent J. Milano Restricted Stock Unit Agreement (Filed With SEC on January 15, 2020)
- Securities Purchase Agreement, dated December 23, 2019, by and among the institutional investors named therein (Filed With SEC on December 23, 2019)
- Form of Warrant (Filed With SEC on December 23, 2019)
- Purchase Agreement, dated as of March 4, 2019, by and between Idera Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 6, 2019)
- Registration Rights Agreement, dated as of March 4, 2019, by and between Idera Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 6, 2019)
- Equity Distribution Agreement, dated November 26, 2018, by and between Idera Pharmaceuticals, Inc. and JMP Securities LLC (Filed With SEC on November 26, 2018)
- Underwriting Agreement, dated as of October 25, 2017, between the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Barclays Capital Inc (Filed With SEC on October 26, 2017)
- IDERA PHARMACEUTICALS, INC. 2017 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 9, 2017)
- Idera Pharmaceuticals, Inc. Common Stock Underwriting Agreement (Filed With SEC on October 7, 2016)
- Idera Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement (Filed With SEC on November 6, 2015)
- Idera Pharmaceuticals, Inc. Common Stock Underwriting Agreement (Filed With SEC on February 13, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 9, 2015)
- Idera Pharmaceuticals, Inc. Policy on Treatment of Stock Options in the Event of Retirement* (Filed With SEC on August 12, 2014)
- IDERA PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 5, 2014)
- 6,841,250 Shares of Common Stock and Pre-FundedWarrants to Purchase 2,158,750 Shares of Common Stock IDERA PHARMACEUTICALS, INC. PURCHASE AGREEMENT (Filed With SEC on February 5, 2014)
- IDERA PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 26, 2013)
- 13,727,251 Shares of Common Stock and Pre-FundedWarrants to Purchase 4,175,975 Shares of Common Stock IDERA PHARMACEUTICALS, INC. PURCHASE AGREEMENT (Filed With SEC on September 26, 2013)
- IDERA PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 15, 2013)
- IDERA PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 15, 2013)
- IDERA PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 15, 2013)